InternationalUSRemember you can easily switch between MIP US and MIP International at any time

MIP European Life Sciences Forum 2018

April 24, Le Méridien Piccadilly London



Download the brochure here

9:00 Registration

9:30 Opening remarks by Michael Loney, managing editor, Managing IP

9:40 Keynote address: Insight from big Pharma: how can IP leaders drive innovations that will bring value to patients and shareholders, changing global views on IP, innovation and access?
Aaron Smethurst , director, intellectual property policy, UCB Pharma

10:00 Responding to the key challenges in life sciences to promote commercial growth

  • Rethinking your European strategy in preparation of Brexit
  • What does Brexit mean for cross-border litigation?
  • The Unified Patent Court – final preparations for 2018
  • Assessing latest trends in preliminary injunctions across Europe

Annemarie Grabrucker, lawyer, European Patent Office (moderator)
Amarjit Purewal , solicitor, Cancer Research Technology 
Francesco Macchetta , director of IP, Bracco 

10:40 Coffee break and networking

11:00 Defending second medical use patents across multijurisdictions

  • Examining the impact of recent litigation: Lyrica
  • To what extent should you be investigating opportunities for new uses of existing medicines?
  • Considerations and tips when choosing where to enforce your second medical use claim
  • Solutions to overcome cross-labelling infringement

Philipp Cepl, partner, DLA Piper 
Beatriz Díaz de Escauriaza
, senior IP counsel, Chemo Pharma

11:40 Patent infringement by equivalents

  • Application of the doctrine of equivalents– what does the judgement mean in practice?
  • What impact will the doctrine have on life sciences companies?
  • Doctrine of equivalence across Europe: analysing different approaches
  • To what extent are we moving towards harmonisation?

Dieter Kuhn , senior patent attorney, DSM
Jody Giesser , senior patent counsel, DSM

12:20 Lunch and networking

13:20 Scope of SPC regulations

  • Identifying and overcoming the challenges of enforcing your SPC’s
  • Applying SPC regulation across different European jurisdictions
  • The need for legal and business certainty - is the regulation still fit for purpose?
  • Case focus: Mylan v Gilead

Marianne Schaffner, partner, Dentons
Fiona Bor, head of IP, Mereo BioPharma 
Campbell Forsyth
, partner, Dentons

14:00 Arrow declarations: beyond biosimilars

  • Application of issues surrounding Arrow declarations
  • To what extent can you receive declarations for the invalidity of pending patents
  • Analysing European approaches to declaratory relief
  • Impact of Supreme Court in Pemetrexed on declaratory relief

Jenny Davies , principal associate, Gowling WLG 
Jason Rutt
, patent attorney, Boult Wade Tennant

14:40 Coffee break and networking

15:00 Recent approaches to pharma litigation in Russia

  • Preparing your IP litigation strategy: who can be sued and for what? Novartis v Nativa
  • Patent linkage: does it work in Russia?
  • Challenging PTE: a counter-measure of infringers- Pfizer v Canonpharma
  • Compulsory license: a new defense against infringement actions

Natalia Nikolaeva , partner, Gorodissky

15:30 Digital era and evolution of life sciences

  • Adapting your strategy for today’s competitive pharmaceutical market
  • Protecting and developing your assets in a digital world
  • Implications of AI and how it is being used to advance drug treatments
  • Collaborating with outside counsel to manage uncertainty and prepare for changes ahead

Rachel Wallis, partner, Greaves Brewster (moderator)
Axel Ferrazzini , managing director, 4ip Council
Chris Wright, invention developer, Iprova

16:10 Close of conference



DLA Piper



Supporting Organisations




PharmaVoice 4ip

More from the Managing IP blog

null null null

null null null

November / December 2019

IP law: are the pressures taking their toll?

Following World Mental Health Day, Max Walters seeks the views of in-house professionals on whether they struggle with workplace pressures, and asks how to improve wellbeing

Most read articles